Cancers,
Год журнала:
2022,
Номер
14(17), С. 4338 - 4338
Опубликована: Сен. 5, 2022
The
COVID-19
pandemic
has
changed
healthcare
systems
around
the
world.
Medical
personnel
concentrated
on
infectious
disease
management
and
treatments
for
non-emergency
diseases
scheduled
surgeries
were
delayed.
We
aimed
to
investigate
change
in
severity
of
thyroid
cancer
before
after
outbreak
Korea.
collected
three
years
data
(2019,
2020,
2021)
patients
who
received
surgery
a
university
hospital
South
Korea
grouped
them
as
"Before
COVID-19",
"After
1-year"
2-years".
total
number
annual
outpatients
declined
significantly
both
new
(1303,
939,
1098
patients)
follow-up
(5584,
4609,
4739
patients).
Clinical
characteristics,
including
age,
sex,
BMI,
preoperative
cytology
results,
surgical
extent,
final
pathologic
diagnosis,
not
COVID-19.
However,
days
from
first
visit
was
increased
(38.3
±
32.2,
58.3
105.2,
47.8
124.7
days,
p
=
0.027).
Papillary
carcinoma
(PTC)
showed
proportions
extrathyroidal
extension,
lymphatic
invasion,
vascular
cervical
lymph
node
metastasis.
Increased
tumor
size
observed
with
follicular
(3.5
2.2,
4.0
1.9,
4.3
2.3
cm,
0.019).
After
outbreak,
poor
prognostic
factors
increased,
an
increase
tumors
observed.
Due
our
study
being
confined
single
tertiary
institution
Incheon
city,
Korea,
nationwide
studies
that
include
primary
clinics
should
be
required
identify
actual
impact
treatment.
Bosnian Journal of Basic Medical Sciences,
Год журнала:
2022,
Номер
unknown
Опубликована: Сен. 16, 2022
The
SARS-CoV-2
infection
causes
COVID-19,
which
has
affected
approximately
six
hundred
million
people
globally
as
of
August
2022.
Organs
and
cells
harboring
angiotensin-converting
enzyme
2
(ACE2)
surface
receptors
are
the
primary
targets
virus.
However,
once
it
enters
body
through
respiratory
system,
virus
can
spread
hematogenously
to
infect
other
organs.
Therefore,
COVID-19
affects
many
organs,
causing
severe
long-term
complications,
even
after
disease
ended,
thus
worsening
quality
life.
Although
is
known
that
system
most
by
infection,
organs/systems
in
short
long
term.
Since
simultaneously
redesigning
diagnostic
therapy
policies
fit
damaged
organs
strongly
recommended.
Even
though
pathophysiology
problems
unknown,
frequency
cases
rises
with
age
existence
preexisting
symptoms.
This
study
aims
update
our
knowledge
multi-organ
dysfunction
interaction
based
on
clinical
theoretical
evidence.
For
this
purpose,
comprehensively
elucidates
recent
studies
effects
multiple
systems,
including
respiratory,
cardiovascular,
gastrointestinal,
renal,
nervous,
endocrine,
reproductive,
immune,
parts
integumentary
system.
Understanding
range
atypical
symptoms
could
improve
surveillance,
limit
transmission,
avoid
additional
multi-organ-system
problems.
Journal of Clinical Medicine,
Год журнала:
2021,
Номер
10(13), С. 2920 - 2920
Опубликована: Июнь 29, 2021
The
review
aimed
to
summarize
advances
in
the
topic
of
endocrine
diseases
and
coronavirus
disease
2019
(COVID-19).Scientific
institutional
websites
databases
were
searched
data
collected
organized,
when
plausible,
angle
discussion
toward
following
clinical
issues.
(1)
Are
patients
with
COVID-19
at
higher
risk
developing
acute
or
late-onset
dysfunction?
(2)
May
underlying
dysfunctions
be
considered
factors
for
poor
prognosis
once
infection
has
occurred?
(3)
there
defined
strategies
manage
despite
pandemic-related
constraints?
Herein,
authors
only
relevant
more
frequently
observed
disorders
related
hypothalamic-pituitary
region,
thyroid
parathyroid
glands,
calcium-phosphorus
homeostasis
osteoporosis,
adrenal
gonads.
Main.
Data
highlight
basis
some
pathophysiological
mechanisms
anatomical
alterations
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2)-induced
dysfunctions.
Some
conditions,
such
as
insufficiency
cortisol
excess,
may
worse
progression
occurred.
These
at-risk
populations
require
adequate
education
avoid
SARS-CoV-2
adequately
medical
therapy
during
pandemic,
even
emergencies.
Endocrine
management
underwent
a
palpable
restraint,
especially
procedures
requiring
obligate
access
healthcare
facilities
diagnostic
therapeutic
purposes.
Strategies
triage
prioritize
consultations,
laboratory,
instrumental
evaluations,
digital
telehealth
solutions
should
implemented
better
deal
this
probably
long-term
situation.
Journal of International Medical Research,
Год журнала:
2022,
Номер
50(2)
Опубликована: Фев. 1, 2022
In
this
review,
I
aim
to
provide
a
complete
overview
of
recent
advances
in
knowledge
regarding
severe
acute
respiratory
syndrome-coronavirus
2
(SARS-CoV-2)-induced
thyroid
dysfunction.
discuss
the
findings
role
SARS-CoV-2
development
dysfunction,
including
subacute
thyroiditis,
Graves’
disease,
non-thyroidal
illness,
thyrotoxicosis
and
Hashimoto’s
thyroiditis
during
subsequent
coronavirus
disease
2019
(COVID-19).
The
gland
entire
hypothalamic–pituitary–thyroid
(HPT)
axis
may
represent
key
targets
SARS-CoV-2.
Thyroid
dysfunction
COVID-19
has
been
documented
clinical
studies
is
usually
reversible.
Most
disorders,
euthyroid
sick
syndrome,
have
as
sequelae
COVID-19,
virus
implicated
aetiology
each.
suggested
trigger
activation
pre-existing
or
autoimmunity.
Furthermore,
patients
with
uncontrolled
are
at
risk
infection-related
consequences.
Because
neutropenia
caused
by
antithyroid
medications,
which
obscure
signs
group
should
receive
special
attention.
It
that
direct
infection
“cytokine
storm”-mediated
autoimmune
effects
on
thyroid.
Frontiers in Endocrinology,
Год журнала:
2022,
Номер
13
Опубликована: Сен. 6, 2022
Background
Observational
studies
have
reported
an
association
between
coronavirus
disease
2019
(COVID-19)
risk
and
thyroid
dysfunction,
but
without
a
clear
causal
relationship.
We
attempted
to
evaluate
the
function
COVID-19
using
bidirectional
two-sample
Mendelian
randomization
(MR)
analysis.
Methods
Summary
statistics
on
characteristics
of
dysfunction
(hypothyroidism
hyperthyroidism)
were
obtained
from
ThyroidOmics
Consortium.
Genome-wide
study
for
susceptibility
its
severity
Host
Genetics
Initiative,
phenotypes
included
hospitalization
very
severe
in
participants.
The
inverse
variance-weighted
(IVW)
method
was
used
as
primary
analysis
method,
supplemented
by
weighted-median
(WM),
MR-Egger,
MR-PRESSO
methods.
Results
adjusted
Bonferroni
correction
thresholds.
forward
MR
estimates
show
no
effect
severity.
reverse
found
that
suggestive
factor
hypothyroidism
(IVW:
OR
=
1.577,
95%
CI
1.065–2.333,
P
0.022;
WM:
1.527,
1.042–2.240,
0.029),
there
lightly
hospitalized
1.151,
1.004–1.319,
0.042;
1.197,
1.023-1.401,
0.023).
There
evidence
supporting
any
phenotype
hyperthyroidism.
Conclusion
Our
results
identified
might
be
potential
hypothyroidism.
Therefore,
patients
infected
with
SARS-CoV-2
should
strengthen
monitoring
function.
Biomolecules,
Год журнала:
2022,
Номер
12(4), С. 556 - 556
Опубликована: Апрель 8, 2022
Long
Coronavirus
disease-19
(COVID-19)
refers
to
the
persistence
of
symptoms
related
infection
with
severe
acute
respiratory
syndrome-coronavirus-2
(SARS-CoV-2).
This
condition
is
described
as
persistent
and
can
manifest
in
various
combinations
signs
symptoms,
such
fatigue,
headache,
dyspnea,
depression,
cognitive
impairment,
altered
perception
smells
tastes.
COVID-19
may
be
due
long-term
damage
different
organs-such
lung,
brain,
kidney,
heart-caused
by
persisting
viral-induced
inflammation,
immune
dysregulation,
autoimmunity,
diffuse
endothelial
damage,
micro
thrombosis.
In
this
review,
we
discuss
potential
biologically
plausible
role
some
vitamins,
essential
elements,
functional
foods
based
on
hypothesis
that
an
individual's
dietary
status
play
important
adjunctive
protective
immunity
against
possibly
its
consequences.
Medical Archives,
Год журнала:
2022,
Номер
76(1), С. 12 - 12
Опубликована: Янв. 1, 2022
Hypothyroidism
occurs
as
a
consequence
of
chronic
autoimmune
inflammation
the
thyroid
gland,
which
due
to
reduced
function
in
secretion
hormones
FT3
and
FT4
requires
replacement
therapy
for
life.
CoV-19
infection
has
shown
many
complications
all
organic
systems,
during
acute
phase
post
COVID
period.The
aim
study
was
a)
compare
frequency
patient
visits
hypothyroidism
average
dose
levothyroxine
SANASA
polyclinic
year
before
pandemic,
early
2019,
with
2020
2021;
b)
determine
incidence
after
19
infection,
time
onset
disease,
levothyroxine;
c)
monitor
subclinical
hypothyroidism,
did
not
require
substitution,
infection.In
from
2019
database
we
found
58
patients,
at
age
between
18-70
years,
53
women
2
men
female
1
male
patients
hypothyroidism.
In
there
were
total
89
73
4
9
3
2021
101
86
7
hypothyroidism.There
significant
difference
number
relation
2019.
The
per
differ
statistically,
comparing
three
well
those
who
ill,
compared
have
COVID-19.
There
diagnoses
2020,
2021,
an
diagnosis
months
clinical
8
weeks
hypothyroidism.CoV-19
adversely
affects
tissue
causing
requiring
substitution
should
be
monitored.
Abstract
Since
the
COVID-19
emergence
as
a
global
pandemic
in
March
2020,
more
than
5
million
SARS-CoV-2-related
deaths
have
been
globally
documented.
As
progressed,
it
became
clear
that,
although
infection
is
mainly
characterized
respiratory
disease,
also
affects
other
organs
and
systems,
including
thyroid
gland.
Indeed,
emerging
evidence
suggests
that
SARS-CoV-2
can
act
trigger
for
various
disorders,
example,
subacute
thyroiditis
(SAT),
Grave’s
non-thyroidal
illness
syndrome.
The
entry
of
into
host
cells
mediated
by
ACE2-receptor,
making
systems
with
high
expression
this
receptor,
such
gland,
highly
vulnerable
to
COVID-19.
Accumulating
data
propose
SAT
may
be
an
underestimated
manifestation
infection.
Importantly,
if
remains
unrecognized,
or
aggravate
potential
complications
insufficiency
cardiovascular
complications,
thus
negatively
influence
prognosis.
Moreover,
recent
case
reports,
series,
systematic
reviews
highlight
side
effect
vaccination
against
SARS-CoV-2.
present
review
aims
raise
awareness
SARS-CoV-2-associated-
post-vaccination
thyroiditis,
discuss
regarding
its
pathophysiology,
useful
information
special
form
related
daily
clinical
practice.